Results 81 to 90 of about 2,108 (191)
Switching to faricimab from the current anti-VEGF therapy: evidence-based expert recommendations
BMJ Open OphthalmologyDual inhibition of the angiopoietin (Ang)/Tie and vascular endothelial growth factor (VEGF) signalling pathways in patients with retinal diseases, such as neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME), may induce ...
Sanjay Sharma +4 more
doaj +1 more source
Safety Evaluation of Bilateral Same-Day Intravitreal Injection of Faricimab
Ophthalmology and TherapyIntroduction Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is the most commonly performed ophthalmic procedure. Many retinal specialists routinely perform same-day bilateral intravitreal anti-VEGF injections, in order to
Michael D. Karampelas +2 more
doaj +1 more source
A CASE OF HYPERTENSIVE UVEITIS WITH INTRAVITREAL FARICIMAB
RETINAL Cases & Brief ReportsPurpose: The aim of this study was to report a novel case of hypertensive uveitis with intravitreal faricimab. Methods: This is a case report. A 69-year-old woman undergoing treatment of bilateral diabetic macular edema with intravitreal faricimab presented for routine review ...
Samantha Kitson, Andrew McAllister
openaire +4 more sources
Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases [PDF]
, 2023 PURPOSE: The purpose of this study was to evaluate clinical reports of response-loss in patients with neovascular eye diseases, such as neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME), after repeated anti-vascular ...
Jia, Haiyan +2 more
core
Journal of Health Economics and Outcomes Research# Background Retinal diseases are major contributors to disability, significantly affecting patients' quality of life. Diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) represent a significant disease and economic ...
Daniel Samacá-Samacá +9 more
doaj +1 more source
Evolving practice patterns of young retinal specialists: A five-year comparison of treatment and surgical preferences [PDF]
Purpose: To describe trends in demographics and practice patterns of young retina specialists over a five-year follow-up period. Design: A cross-sectional study of young retinal specialists conducted through an online social media platform to evaluate ...
Huang, Vincent +5 more
core +2 more sources
Faricimab for retinal vein occlusion: a review of current evidence and future perspectives. [PDF]
Front PharmacolRetinal vein occlusion (RVO) is the second most common retinal vascular cause of vision loss after diabetic retinopathy and can lead to substantial visual impairment due to retinal ischemia, hemorrhage, vascular leakage, and macular edema.
Jing Y, Li D.
europepmc +3 more sources
Exploring current molecular targets in the treatment of neovascular age-related macular degeneration toward the perspective of long-term agents [PDF]
Long-lasting anti-vascular endothelial growth factor (anti-VEGF) agents have become an option to reduce treatment frequency, with ongoing research exploring optimal responses and safety profiles. This review delves into molecular targets, pharmacological
Abdolrahimzadeh, Barmak +5 more
core +1 more source
Recurrent uveitic macular edema managed with intravitreal faricimab injection
Journal of Ophthalmic Inflammation and InfectionPurpose To present a case of recurrent uveitic macular edema (UME) treated with intravitreal faricimab injection. Methods Single case report from a tertiary referral center. Observations A 63-year-old Caucasian female presenting with recurrent UME due to
Negin Yavari +6 more
doaj +1 more source
BMJ Open OphthalmologyObjective To evaluate the efficacy and safety of faricimab compared with other anti-vascular endothelial growth factor (anti-VEGF) agents in treating neovascular age-related macular degeneration (nAMD) patients.Methods and analysis A systematic review ...
Francisco Rodríguez +7 more
doaj +1 more source